Institutional investors hold a majority ownership of ABBV through the 70.25% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2013, these large investors purchased a net $25.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STANDARD LIFE INVESTMENTS, INC. ... Bought 584.2 Thousand shares of AbbVie Inc
PYRAMIS GLOBAL ADVISORS (CANADA)... Bought 282.4 Thousand shares of AbbVie Inc
STILLWATER CAPITAL ADVISORS LLC Bought 159.2 Thousand shares of AbbVie Inc